Mar 2, 2026 08:00AM
Feb 18, 2026 08:00AM
Feb 9, 2026 01:43PM
Feb 9, 2026 08:01AM
Feb 9, 2026 08:00AM
Jan 8, 2026 08:00AM
Jan 5, 2026 08:01AM Humacyte plans to file for marketing approval of Symvess in Israel
Jan 5, 2026 08:00AM
Dec 22, 2025 08:00AM
Dec 16, 2025 08:01AM
Dec 16, 2025 08:00AM
Nov 20, 2025 08:00AM
Nov 13, 2025 08:00AM
Nov 12, 2025 07:00AM Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Nov 6, 2025 08:00AM
Oct 30, 2025 08:00AM
Oct 7, 2025 09:00AM
Oct 7, 2025 09:00AM
Oct 6, 2025 08:04AM Humacyte reports long-term results for combat injury treatment in Ukraine
Oct 6, 2025 08:00AM
Sep 29, 2025 08:01AM
Sep 29, 2025 08:00AM
Sep 18, 2025 07:03AM
Sep 18, 2025 07:00AM
Sep 15, 2025 07:01AM
Sep 15, 2025 07:00AM Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
Aug 11, 2025 07:00AM
Aug 7, 2025 08:00AM
Jul 23, 2025 08:00AM
Jul 8, 2025 08:10AM
Jul 8, 2025 08:00AM
Jun 9, 2025 08:00AM
Jun 2, 2025 08:00AM Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3
May 19, 2025 04:05PM
May 13, 2025 07:30AM
May 9, 2025 08:00AM
Mar 28, 2025 07:30AM
Mar 27, 2025 06:00PM
Mar 26, 2025 03:41PM
Mar 26, 2025 08:00AM Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025
Mar 25, 2025 08:39PM
Mar 25, 2025 08:35PM
Mar 25, 2025 04:01PM
Mar 25, 2025 04:01PM
Mar 10, 2025 08:02AM
Mar 10, 2025 08:00AM
Mar 6, 2025 08:00AM Trestle Bio Announces Research Collaboration with Humacyte
Mar 3, 2025 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All